Zynerba Pharmaceuticals, Inc. appointed Warren Cooper as a Lead Independent Director. In this role, Dr. Cooper, who has served as one of Zynerba's independent directors since August 2015, will act as a key liaison between the Chairman and the independent directors, among other responsibilities Dr. Cooper is a UK-trained physician with more than 35 years of experience in the global pharmaceutical industry. Previously, Dr. Cooper was the CEO of Prism Pharmaceuticals, a venture-backed, specialty pharmaceutical company that he led from inception in September 2004 until the sale of the Company to Baxter International in May 2011.